Workflow
Stereotaxis(STXS)
icon
Search documents
Stereotaxis(STXS) - 2020 Q2 - Earnings Call Transcript
2020-08-09 16:19
Stereotaxis, Inc. (NYSE:STXS) Q2 2020 Earnings Conference Call August 6, 2020 10:00 AM ET Company Participants David Fischel - Chairman & Chief Executive Officer Kim Peery - Chief Financial Officer Conference Call Participants Josh Jennings - Cowen Frank Takkinen - Lake Street Capital Markets Operator Good morning. Thank you for joining us for Stereotaxis' Second Quarter 2020 Earnings Conference Call. Certain statements during the conference call and question-and-answer period to follow may relate to future ...
Stereotaxis(STXS) - 2020 Q1 - Earnings Call Transcript
2020-05-05 21:06
Stereotaxis, Inc. (NYSE:STXS) Q1 2020 Earnings Conference Call May 5, 2020 10:00 AM ET Company Participants David Fischel - Chairman & Chief Executive Officer Kim Peery - Chief Financial Officer Conference Call Participants Josh Jennings - Cowen Frank Takkinen - Lake Street Capital Kyle Bauser - Dougherty & Company Operator Good morning. Thank you for joining us for Stereotaxis First Quarter 2020 Earnings Conference Call. Certain statements during the conference call and question-and-answer period to follow ...
Stereotaxis(STXS) - 2019 Q4 - Earnings Call Transcript
2020-03-10 18:15
Stereotaxis, Inc. (NYSE:STXS) Q4 2019 Earnings Conference Call March 10, 2020 10:00 AM ET Company Participants David Fischel - CEO & Chairman Kimberly Peery - CFO Conference Call Participants Josh Jennings - Cowen Chris Vaster - private investor Edward Gilmore - Little Grapevine Robert Riley - Clark Capital Management Brian Rackman - Retail Investor Operator Good morning. Thank you for joining us for Stereotaxis Fourth Quarter and Full Year 2019 Earnings Conference Call. Certain statements during the confer ...
Stereotaxis(STXS) - 2019 Q3 - Earnings Call Transcript
2019-11-14 21:14
Stereotaxis, Inc. (NYSE:STXS) Q3 2019 Earnings Conference Call November 14, 2019 9:00 AM ET Company Participants David Fischel - CEO & Chairman Kimberly Peery - CFO Conference Call Participants Joshua Jennings - Cowen and Company Guy Judkowski - Logan Capital Management John Morganelli - Private Investor Operator Good morning. Thank you for joining us for the Stereotaxis Third Quarter 2019 Earnings Conference Call. Certain statements during the conference call and the question-and-answer period to follow ma ...
Stereotaxis(STXS) - 2019 Q1 - Earnings Call Transcript
2019-05-09 15:41
Stereotaxis, Inc. (NYSE:STXS) Q1 2019 Earnings Conference Call May 9, 2019 9:00 AM ET Company Participants David Fischel - CEO & Chairman Martin Stammer - CFO Conference Call Participants Joshua Jennings - Cowen and Company Operator Good morning. Thank you for joining us for Stereotaxis First Quarter 2019 Earnings Conference Call. Certain statements during the conference call and question-and-answer period to follow may relate to future events, expectations and, as such, constitute forward-looking statement ...
Stereotaxis(STXS) - 2018 Q4 - Earnings Call Transcript
2019-03-12 18:27
Stereotaxis, Inc. (NYSE:STXS) Q4 2018 Earnings Conference Call March 12, 2019 10:00 AM ET Company Representatives David Fischel - Chairman, Chief Executive Officer Marty Stammer - Chief Financial Officer Conference Call Participants Chris Vaster - Private Investor Operator Good morning. Thank you for joining us for the Stereotaxis Fourth Quarter and Full Year 2018 Earnings Conference Call. Certain statements during the conference call and question-and-answer session to follow may relate to future events, ex ...
Stereotaxis(STXS) - 2018 Q4 - Earnings Call Presentation
2019-03-12 13:38
Investor Presentation 4Q 2018 2 Stereotaxis at a Glance Global Leader in Endovascular Robotics Focused on the Treatment of Cardiac Arrhythmias Extensive Presence 300+ Physicians | 100+ Active Systems | 31 Countries . Validated & Protected 100,000+ Procedures | 300+ Publications | 100+ Issued Patents. Attractive Market $4B+ Existing Market | 10-15% Annual Growth | No Robotic Competitor Financial Highlights* >$30m Sales | >80% Recurring Revenue | >75% Gross Margin . $12.0m Cash and No Debt Enterprise Value ~$ ...